I agree, bringing patients out of the ventilator earlier save cost, ventilator space, life's, but secondary outcomes can only be interpreted if the primary end point is stylistically significant. That's just the normal rule of interpreting clinical trials. So the primary end point is the most important outcome that must be met.
- Forums
- ASX - By Stock
- MSB
- Overwhelming efficacy - the stats required
Overwhelming efficacy - the stats required, page-215
-
-
- There are more pages in this discussion • 362 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 71720 | 94.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 10463 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 71720 | 0.940 |
7 | 80257 | 0.935 |
5 | 107550 | 0.930 |
6 | 117669 | 0.925 |
6 | 104084 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 10463 | 1 |
0.950 | 71797 | 3 |
0.955 | 114621 | 4 |
0.960 | 92017 | 5 |
0.965 | 44050 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |